SK pharmteco announces $35m investment in Phase 1 of new expansion plan for SK biotek Ireland’s Swords Campus
SK pharmteco (SKPT) a global CDMO, part of SK Inc., is pleased to announce Dollar 35m investment for the initial phase of an expansion plan for SK biotek Ireland’s Dublin-based pharmaceutical manufacturing plant.